Variant report

Variant	rs16934755
Chromosome Location	chr9:16510059-16510060
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 20 )
Associated
traits (count: 1 )

rSNPs within LD-proxies of this variant (count:12)

rs_ID	r²[population]
rs10119720	1.00[CEU][hapmap]
rs10962451	1.00[CEU][hapmap]
rs16934806	1.00[CEU][hapmap]
rs56062233	1.00[EUR][1000 genomes]
rs57046305	0.94[AFR][1000 genomes]
rs58501660	0.80[AFR][1000 genomes]
rs7018594	1.00[CEU][hapmap]
rs7029578	1.00[CEU][hapmap]
rs7029648	1.00[CEU][hapmap]
rs7031782	1.00[CEU][hapmap];0.89[EUR][1000 genomes]
rs7847768	1.00[CEU][hapmap]
rs943748	1.00[CEU][hapmap]

Variant overlapped rSNPs/rCNVs (count:8 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv530933	chr9:16251206-16830845	Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	13 gene(s)	inside rSNPs	diseases
2	nsv530934	chr9:16281246-16779432	Strong transcription Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	13 gene(s)	inside rSNPs	diseases
3	nsv1032856	chr9:16465330-16773471	Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Strong transcription Genic enhancers Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	11 gene(s)	inside rSNPs	diseases
4	nsv540073	chr9:16465330-16773471	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	11 gene(s)	inside rSNPs	diseases
5	nsv892646	chr9:16476144-16514375	Enhancers Weak transcription Flanking Active TSS Strong transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Active TSS	lncRNA	n/a	inside rSNPs	diseases
6	nsv892647	chr9:16476144-16521534	Enhancers Weak transcription Strong transcription Flanking Active TSS Genic enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	n/a	inside rSNPs	diseases
7	nsv466265	chr9:16484731-16516941	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Genic enhancers Strong transcription Bivalent/Poised TSS	n/a	n/a	inside rSNPs	diseases
8	nsv613670	chr9:16484731-16516941	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent/Poised TSS Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	inside rSNPs	diseases

mRNA abundance (count:1)

SNP	Gene	Cis/trans	Tissue	Source
rs16934755	SF1	trans	lymphoblastoid	RTeQTL

Chromatin state (count:53 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:16483200-16513600	Weak transcription	Psoas Muscle	Psoas
2	chr9:16500400-16514000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
3	chr9:16505400-16510200	Weak transcription	NHEK	skin
4	chr9:16505400-16514000	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
5	chr9:16506000-16513600	Weak transcription	H1 Cell Line	embryonic stem cell
6	chr9:16506000-16514200	Weak transcription	NHDF-Ad	bronchial
7	chr9:16506000-16515200	Weak transcription	Adipose Nuclei	Adipose
8	chr9:16506200-16515000	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
9	chr9:16506400-16510200	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
10	chr9:16506400-16510200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
11	chr9:16506400-16510200	Weak transcription	Duodenum Smooth Muscle	Duodenum
12	chr9:16506600-16514000	Weak transcription	Fetal Lung	lung
13	chr9:16509000-16510600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
14	chr9:16509200-16510400	Enhancers	Ovary	ovary
15	chr9:16509400-16510200	Enhancers	Skeletal Muscle Male	skeletal muscle
16	chr9:16509400-16510800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
17	chr9:16509400-16510800	Enhancers	Muscle Satellite Cultured Cells	--
18	chr9:16509400-16511000	Enhancers	Colon Smooth Muscle	Colon
19	chr9:16509400-16511200	Enhancers	ES-I3 Cell Line	embryonic stem cell
20	chr9:16509600-16510400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
21	chr9:16509600-16510400	Enhancers	Fetal Stomach	stomach
22	chr9:16509600-16510800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
23	chr9:16509800-16510200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
24	chr9:16509800-16510200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
25	chr9:16509800-16510200	Enhancers	Aorta	Aorta
26	chr9:16509800-16510200	Enhancers	Rectal Smooth Muscle	rectum
27	chr9:16509800-16510400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
28	chr9:16509800-16510400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
29	chr9:16509800-16510400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
30	chr9:16509800-16510400	Enhancers	Cortex derived primary cultured neurospheres	brain
31	chr9:16509800-16510400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
32	chr9:16509800-16510600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
33	chr9:16509800-16510600	Enhancers	Placenta Amnion	Placenta Amnion
34	chr9:16509800-16510600	Enhancers	HSMM	muscle
35	chr9:16509800-16510600	Enhancers	NH-A	brain
36	chr9:16509800-16510800	Enhancers	iPS-20b Cell Line	embryonic stem cell
37	chr9:16509800-16511000	Enhancers	Hela-S3	cervix
38	chr9:16509800-16511200	Enhancers	NHLF	lung
39	chr9:16509800-16511400	Enhancers	HUES64 Cell Line	embryonic stem cell
40	chr9:16510000-16510200	Enhancers	Stomach Smooth Muscle	stomach
41	chr9:16510000-16510400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
42	chr9:16510000-16510400	Enhancers	H9 Cell Line	embryonic stem cell
43	chr9:16510000-16510400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
44	chr9:16510000-16510400	Flanking Active TSS	A549	lung
45	chr9:16510000-16510400	Enhancers	HSMMtube	muscle
46	chr9:16510000-16510600	Enhancers	HMEC	breast
47	chr9:16510000-16510800	Enhancers	iPS-18 Cell Line	embryonic stem cell
48	chr9:16510000-16510800	Enhancers	Osteobl	bone
49	chr9:16510000-16511000	Enhancers	HUES48 Cell Line	embryonic stem cell
50	chr9:16510000-16511000	Enhancers	HUES6 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links